RESCON USA Summit 2024
RESCON Summit brings together leading experts from the pharmaceutical, biotechnology industry, and academia. The conference showcases cutting-edge innovations, emerging trends, and the latest advancements in respiratory drug delivery, aerosol science, device design, and digital applications and offers a valuable platform for knowledge exchange, networking, and shaping the future of inhalation and respiratory therapeutics.
Date: November 14-15, 2024
Location: New York City, NY
JOIN US!
Catalent Inhalation has the capabilities, expertise, and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. Complete the form to schedule a meeting with the Catalent Inhalation team at RESCON Summit to discuss how we can partner and help bring your inhaled therapy to market, faster.
FEATURED SPEAKING SESSION
Title: Emerging Trends in Nasal Drug Development and Delivery
Date: Thursday, November 14, 2024
Time: 12:00 – 12:30 PM EST
Speaker: Mark Ignaczak, Director, Innovation and Partnerships – Nasal Delivery
PANEL DISCUSSION
Title: Evolving Regulatory and Policy Approaches in Respiratory Health
Date: Thursday, November 14, 2024
Time: 4:30 – 5:00 PM EST
Moderator: Carla Vozone, Vice President – Specialty Drugs
SESSION SPEAKER
Mark Ignaczak
Director, Innovation and Partnerships
Nasal Delivery
Catalent
PANEL MODERATOR
Carla Vozone
Vice President
Specialty Drugs
Catalent
ABOUT CATALENT INHALATION
Catalent Inhalation has the capabilities, expertise, and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. With over 30 years of inhalation product experience, Catalent can handle the most complex projects and help bring therapies to market faster. Whether a single service or a comprehensive development package is required, Catalent offers end-to-end expertise in dry powders for inhalation (DPI), unit-dose liquid and powder, bi-dose and preserved multi-dose nasal sprays. Our DPI expertise lies in spray-dried or lactose blended powders for inhalation, encapsulation and blistering. In addition, Catalent provides comprehensive analytical, bioanalytical and clinical supply services.
